-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Adaptive Biotechnologies Corp annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2017 to 31 Dec 2025.
- Adaptive Biotechnologies Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $5,451,000, a 12289% increase year-over-year.
- Adaptive Biotechnologies Corp annual Net Cash Provided by (Used in) Financing Activities for 2025 was $30,403,000, a 12515% increase from 2024.
- Adaptive Biotechnologies Corp annual Net Cash Provided by (Used in) Financing Activities for 2024 was $241,000, a 89% decline from 2023.
- Adaptive Biotechnologies Corp annual Net Cash Provided by (Used in) Financing Activities for 2023 was $2,245,000, a 98% decline from 2022.